References
- Kambe T, Yamaguchi-Iwai Y, Sasaki R, . Overview of mammalian zinc transporters. Cell Mol Life Sci. 2004; 61:49–68.
- Chimienti F, Devergnas S, Favier A, . Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes. 2004; 53:2330–2337.
- Chimienti F, Favier A, Seve M. ZnT-8, a pancreatic beta-cell-specific zinc transporter. Biometals. 2005; 18:313–317.
- Qian WJ, Aspinwall CA, Battiste MA, . Detection of secretion from single pancreatic beta-cells using extracellular fluorogenic reactions and confocal fluorescence microscopy. Anal Chem. 2000; 72:711–717.
- Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr. 1998; 17:109–115.
- Wenzlau JM, Juhl K, Yu L, . The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Nat Acad Sci USA. 2007; 104:17040–17045.
- Wenzlau JM, Hutton JC, Davidson HW. New antigenic targets in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2008; 15:315–320.
- Achenbach P, Lampasona V, Landherr U, . Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia. 2009; 52:1881–1888.
- Kawasaki E, Nakamura K, Kuriya G, . Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients. Clin Immunol. 2010; 138:146–153.
- de Grijse J, Asanghanwa M, Nouthe B, . Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: Implications for prevention trials. Diabetologia. 2010; 53:517–524.
- Lampasona V, Petrone A, Tiberti C, . Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non insulin requiring autoimmune diabetes (NIRAD) 4. Diabetes Care. 2010; 33:104–108.
- Sladek R, Rocheleau G, Rung J, . A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445:881–885.
- Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997; 20:1183–1197.
- Matthews DR, Cull CA, Stratton IM, . UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabetic Med. 1998; 15:297–303.
- Valdez SN, Sica MP, Labovsky V, . Combined measurement of diabetes mellitus immunological markers: An assessment of its benefits in adult-onset patients. Autoimmunity. 2001; 33:227–236.
- Valdez SN, Iacono RF, Villalba A, . A radioligand-binding assay for detecting antibodies specific for proinsulin and insulin using 35S-proinsulin. J Immunol Meth. 2003; 279:173–181.
- Wenzlau JM, Moua O, Liu Y, . Identification of a major humoral epitope in Slc30A8 (ZnT8). Ann NY Acad Sci. 2008; 1150:252–255.
- Kawasaki E, Nakamura K, Kuriya G, . Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metabol. 2010; 95:707–713.